Veracyte Inc is a company in the U.S. stock market and it is a holding in 61 U.S.-traded ETFs. VCYT has around 14.0M shares in the U.S. ETF market. The largest ETF holder of VCYT is the ARK Innovation ETF (ARKK), with approximately 3.30M shares. Investors may also find of interest that the ETF with the largest allocation to VCYT stock is Invesco Dynamic Biotechnology & Genome ETF (PBE), with a portfolio weight of 3.29%. On average, U.S. ETFs allocate 0.37% of VCYT to their portfolios.
Additionally, VCYT is a favorite stock for Vanilla and Active ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with VCYT as a holding is the ProShares UltraPro Russell2000 (URTY), with a return of 167.77%.